A nomogram model for predicting ocular GVHD following allo-HSCT based on risk factors

Autor: Wen-hui Wang, Li-li You, Ke-zhi Huang, Zi-jing Li, Yu-xin Hu, Si-min Gu, Yi-qing Li, Jian-hui Xiao

Publikováno v: BMC Ophthalmology, Vol 23, Iss 1, Pp 1-9 (2023)

Abstract Objective To develop and validate a nomogram model for predicting chronic ocular graft-versus-host disease (coGVHD) in patients after allogenic haematopoietic stem cell transplantation (allo-HSCT). Methods This study included 61 patients who

Externí odkaz: https://doaj.org/article/8d4a0f46225948deb5750ff33be7f72d

GATA2 haploinsufficient patients lack innate lymphoid cells that arise after hematopoietic cell transplantation

Autor: Y. F. van Lier, L. Krabbendam, N. J. E. Haverkate, S. S. Zeerleder, C. E. Rutten, B. Blom, H. Spits, M. D. Hazenberg

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

Innate lymphoid cells (ILC) are important barrier tissue immune regulators. They play a pivotal role in early non-specific protection against infiltrating pathogens, regulation of epithelial integrity, suppression of pro-inflammatory immune responses

Externí odkaz: https://doaj.org/article/eb574ab2ffc84f22a578dca8b8f8a74b

Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission

Autor: Arnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, Didier Blaise, Sergey Bondarenko, Jan Vydra, Goda Choi, Montserrat Rovira, Péter Reményi, Ellen Meijer, Claude Eric Bulabois, J. L. Diez‐Martin, Ibrahim Yakoub‐Agha, Eolia Brissot, Alexandros Spyridonidis, Jaime Sanz, Amit Patel, Mutlu Arat, Ali Bazarbachi, Gesine Bug, Bipin N. Savani, Sebastian Giebel, Fabio Ciceri, Mohamad Mohty

Publikováno v: British Journal of Haematology, 201(6), 1169-1178. Wiley-Blackwell
Nagler, A, Labopin, M, Dholaria, B, Blaise, D, Bondarenko, S, Vydra, J, Choi, G, Rovira, M, Reményi, P T, Meijer, E, Bulabois, C E, Diez-Martin, J L, Yakoub-Agha, I, Brissot, E, Spyridonidis, A, Sanz, J, Patel, A, Arat, M, Bazarbachi, A, Bug, G, Savani, B N, Giebel, S, Ciceri, F & Mohty, M 2023, ' Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission ', British Journal of Haematology, vol. 201, no. 6, pp. 1169-1178 . https://doi.org/10.1111/bjh.18765
British Journal of Haematology, 201(6), 1169-1178. Wiley

Pre-transplant measurable residual disease (MRD) predicts relapse and outcome of allogeneic haematopoietic cell transplantation (allo-HCT). The impact of MRD on the outcomes of post-transplant cyclophosphamide (PTCy)-based allo-HCT from a matched unr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::414665e282a2086b20801c7d2073acbc
https://doi.org/10.1111/bjh.18765

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.